Phase II Pilot Study of Early Cortisol Replacement to Prevent Bronchopulmonary Dysplasia

NCT00004669 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

NIH

Sponsor class

Conditions

Bronchopulmonary Dysplasia

Interventions

DRUG: hydrocortisone

Sponsor

National Center for Research Resources (NCRR)

Collaborators

[object Object]